Regulatory T cells and autoimmune hepatitis: What happens in the liver stays in the liver

Journal of Hepatology

Volumn 61, Issue 5, 2014, Pages 973-975

  Oo, Ye H ^a,b   Adams, David H ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autoimmune hepatitis; B cells; FOXP3; Immunosuppression; Microenvironment; Regulatory T cells; Th17 cells; Tolerance

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE HEPATITIS; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; FEMALE; IMMUNOLOGY; MALE; PATHOLOGY;

FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84938529721     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.005     Document Type: Editorial

References (20)

1. Tait B, Mackay IR, Board P, Coggan M, Emery P, Eckardt G. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis. Gastroenterology 1989;97: 479-481.
2. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. QJM 1971;40: 159-185.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-Tolerance causes various autoimmune diseases. J Immunol 1995;155: 1151-1164.
4. Putnam AL, Safinia N, Medvec A, Laszkowska M, Wray M, Mintz MA, et al. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant 2013;13: 3010-3020.
5. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006;43: S54-S62.
6. Oo YH, Weston CJ, Lalor PF, Curbishley SM, Withers DR, Reynolds GM, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 2010;184: 2886-2898.
7. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000;174: 5-20.
8. + LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology 1996;24: 1416-1421.
9. Taubert R, Hardtke-Wolenski M, Noyan F, Wilms A, Baumann AK, Schlue J, et al. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. J Hepatol 2014;61: 1106-1114.
10. + CD25+ regulatory T cells. Nat Immunol 2003;4: 330-336.
11. Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, et al. Livertargeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006;43: 729-737.
12. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008;29: 44-56.
13. Carambia A, Freund B, Schwinge D, Heine M, Laschtowitz A, Huber S, et al. TGF-beta-dependent induction of CD4CD25Foxp3 Tregs by liver sinusoidal endothelial cells. J Hepatol 2014.
14. Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, et al. Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol 2013;190: 2009-2016.
15. Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008;38: 1654-1663.
16. Granelli-Piperno A, Nolan P, Inaba K, Steinman RM. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J Exp Med 1990;172: 1869-1872.
17. Ferraro AJ, Drayson MT, Savage CO, MacLennan IC. Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. Eur J Immunol 2008;38: 292-298.
18. + CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006;176: 4484-4491.
19. Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol 2012;57: 125-132.
20. Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010;52: 999-1007.